Pediatric Cardiology

, Volume 34, Issue 1, pp 170–178 | Cite as

The Fate and Observed Management of Giant Coronary Artery Aneurysms Secondary to Kawasaki Disease in the Province of Quebec: The Complete Series Since 1976

  • Ariane McNeal-Davidson
  • Anne Fournier
  • Rosie Scuccimarri
  • Adrian Dancea
  • Christine Houde
  • Marc Bellavance
  • Nagib DahdahEmail author
Original Article


Most population-based series reporting on the coronary artery complications after Kawasaki disease (KD) originate from Japan. This study aimed to describe the complete series of KD patients from the province of Quebec in Canada, a predominantly Caucasian population. This retrospective case series was conducted by the Quebec Kawasaki Disease Registry, a multi-institutional collaboration reviewing 89.8 % of all KD cases identified by the Ministry of Health records of hospitalization for KD from the first recognized case in 1976 until 2008. This report describes the course of 38 patients (95 % Caucasians) with a diagnosis of giant coronary artery aneurysms, which represent 1.9 % of all reviewed cases and 26.2 % of those with a coronary aneurysm 5 mm or larger. The age at diagnosis was 5.52 ± 4.04 years, and the follow-up period was 9.26 ± 6.9 years. The KD diagnosis was retrospective at autopsy in two cases and via echocardiography in four cases. The overall freedom from coronary thrombi, coronary intervention, or death was respectively 63.9, 67.5, and 85.1 %. Five deaths occurred as follows: 21 days after onset of fever (2 cases), 1.8 months after onset of fever (1 case), 1 year after retrospectively presumed but previously undiagnosed KD (1 case), and 5.7 years after a KD diagnosis (1 case of sudden cardiac death). Percutaneous transluminal coronary revascularization was attempted in four cases (1 requiring cardiac transplantation), and two other cases underwent primary bypass graft surgery. Whereas this study investigated cases of KD with severe coronary sequelae in the Province of Quebec, larger collaborative studies should be conducted for further understanding of the disease in predominantly non-Asian populations.


Caucasian Giant coronary Kawasaki disease Outcome 



This work was partially funded by Foundation En Coeur, Foundation des enfants cardiaques du Québec.

Conflict of interest



  1. 1.
    Akagi T, Rose V, Benson LN, Newman A, Freedom RM (1992) Outcome of coronary artery aneurysms after Kawasaki disease. J Pediatr 121:689–694PubMedCrossRefGoogle Scholar
  2. 2.
    Akagi T, Ogawa S, Ino T, Iwasa M, Echigo S, Kishida K, Baba K, Matsushima M, Hamaoka K, Tomita H, Ishii M, Kato H (2000) Catheter interventional treatment in Kawasaki disease: a report from the Japanese Pediatric Interventional Cardiology Investigation Group. J Pediatr 137:181–186PubMedCrossRefGoogle Scholar
  3. 3.
    Alloul S, Dahdah N, Miró J (2009) Thrombus in a coronary artery aneurysm shortly after warfarin withdrawal. Pediatr Cardiol 30:188–190PubMedCrossRefGoogle Scholar
  4. 4.
    Burns JC, Kushner HI, Bastian JF, Shike H, Shimizu C, Matsubara T, Turner CL (2000) Kawasaki disease: a brief history. Pediatrics 106:e27PubMedCrossRefGoogle Scholar
  5. 5.
    Dahdah NS, Fournier A, Jaeggi E, van Doesburg NH, Lambert R, Dionne N, Sauvé C (1999) Segmental myocardial contractility versus perfusion in Kawasaki disease with coronary arterial aneurysm. Am J Cardiol 83:48–51PubMedCrossRefGoogle Scholar
  6. 6.
    Dahdah N, Ibrahim R, Cannon L (2007) First recanalization of a coronary artery chronic total obstruction in an 11-year-old child with Kawasaki disease sequelae using the CROSSER catheter. Pediatr Cardiol 28:193–389CrossRefGoogle Scholar
  7. 7.
    Dallaire F, Dahdah N (2011) New equations and a critical appraisal of coronary artery z-scores in healthy children. J Am Soc Echocardiogr 24:60–74PubMedCrossRefGoogle Scholar
  8. 8.
    Fujiwara H, Hmashima Y (1978) Pathology of the heart in Kawasaki disease. Pediatrics 61:100–107PubMedGoogle Scholar
  9. 9.
    Fujiwara T, Fujiwara H, Hamashima H (1987) Size of coronary aneurysm as a determinant factor of the prognosis in Kawasaki disease: clinicopathologic study of coronary aneurysms. Prog Clin Biol Res 250:519–520PubMedGoogle Scholar
  10. 10.
    Fulton DR, Newburger JW (2000) Long-term cardiac sequelae of Kawasaki disease. Curr Rheumatol Rep 2:324–329PubMedCrossRefGoogle Scholar
  11. 11.
    Furuyama H, Odagawa Y, Katoh C, Iwado Y, Ito Y, Noriyasu K, Mabuchi M, Yoshinaga K, Kuge Y, Kobayashi K, Tamaki N (2003) Altered myocardial flow reserve and endothelial function late after Kawasaki disease. J Pediatr 142:149–154PubMedCrossRefGoogle Scholar
  12. 12.
    Hayasaka S, Nakamura Y, Yashiro M, Uehara R, Oki I, Tajimi M, Ojima T, Terai M, Yanagawa H (2003) Analyses of fatal cases of Kawasaki disease in Japan using vital statistical data over 27 years. J Epidemiol 13:246–250PubMedCrossRefGoogle Scholar
  13. 13.
    Holman RC, Curns AT, Belay ED, Steiner CA, Schonberger LB (2003) Kawasaki syndrome hospitalizations in the United States, 1997 and 2000. Pediatrics 112:495–501PubMedCrossRefGoogle Scholar
  14. 14.
    Holman RC, Christensen KY, Belay ED, Steiner CA, Effler PV, Miyamura J, Forbes S, Schonberger LB, Melish M (2010) Racial/ethnic differences in the incidence of Kawasaki syndrome among children in Hawaii. Hawaii Med J 69:194–197PubMedGoogle Scholar
  15. 15.
    Kato H, Ichinose E, Kawasaki T (1986) Myocardial infarction in Kawasaki disease: clinical analyses in 195 cases. J Pediatr 108:923–927PubMedCrossRefGoogle Scholar
  16. 16.
    Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, Kazue T, Eto G, Yamakawa R (1996) Long-term consequence of Kawasaki disease: a 10- to 21-year follow-up study of 594 patients. Circulation 94:1379–1385PubMedCrossRefGoogle Scholar
  17. 17.
    Lapierre C, Bitsch A, Guérin R, Garel L, Miró J, Dahdah N (2010) Follow-up chest X-ray in patients with Kawasaki disease: the significance and clinical application of coronary artery macro-calcification. Pediatr Cardiol 31:56–61PubMedCrossRefGoogle Scholar
  18. 18.
    Levy DM, Silverman ED, Massicotte MP, McCrindle BW, Yeung RS (2005) Long-term outcomes in patients with giant aneurysms secondary to Kawasaki disease. J Rheumatol 32:928–934PubMedGoogle Scholar
  19. 19.
    Manlhiot C, Brandão LR, Somji Z, Chesney AL, MacDonald C, Gurofsky RC, Sabharwal T, Chahal N, McCrindle BW (2010) Long-term anticoagulation in Kawasaki disease: initial use of low-molecular-weight heparin is a viable option for patients with severe coronary artery abnormalities. Pediatr Cardiol 31:834–842PubMedCrossRefGoogle Scholar
  20. 20.
    Manlhiot C, Millar K, Golding F, McCrindle BW (2010) Improved classification of coronary artery abnormalities based only on coronary artery z-scores after Kawasaki disease. Pediatr Cardiol 31:242–249PubMedCrossRefGoogle Scholar
  21. 21.
    McCrindle BW, Li JS, Minich LL, Colan SD, Atz AM, Takahashi M, Vetter VL, Gersony WM, Mitchell PD, Newburger JW (2007) Pediatric Heart Network Investigators Coronary artery involvement in children with Kawasaki disease: risk factors from analysis of serial normalized measurements. Circulation 116:174–179PubMedCrossRefGoogle Scholar
  22. 22.
    Nakamura Y, Aso E, Yashiro M, Uehara R, Watanabe M, Tajimi M, Oki I, Ojima T, Yanagawa H, Kawasaki T (2005) Mortality among persons with a history of Kawasaki disease in Japan: can paediatricians safely discontinue follow-up of children with a history of the disease but without cardiac sequelae? Acta Paediatr 94:429–434PubMedCrossRefGoogle Scholar
  23. 23.
    Nakano H, Ueda K, Saito A, Nojima K (1985) Repeated quantitative angiograms in coronary arterial aneurysm in Kawasaki disease. Am J Cardiol 56:846–851PubMedCrossRefGoogle Scholar
  24. 24.
    Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman ST, Bolger AF, Ferrieri P, Baltimore RS, Wilson WR, Baddour LM, Levison ME, Pallasch TJ, Falace DA, Taubert KA (2004) Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 110:2747–2771PubMedCrossRefGoogle Scholar
  25. 25.
    Olivieri L, Arling B, Friberg M, Sable C (2009) Coronary artery z-score regression equations and calculators derived from a large heterogeneous population of children undergoing echocadiography. J Am Soc Echocardiogr 22:159–164PubMedCrossRefGoogle Scholar
  26. 26.
    Pantos I, Patatoukas G, Katritsis DG, Efstathopoulos E (2009) Patient radiation doses in interventional cardiology procedures. Curr Cardiol Rev 5:1–11PubMedCrossRefGoogle Scholar
  27. 27.
    Research Committee on Kawasaki disease (1984) Report of subcommittee on standardization of diagnostic criteria and reporting of coronary artery lesions in Kawasaki disease. Ministry of Health and Welfare, Tokyo, JapanGoogle Scholar
  28. 28.
    Sasaguri Y, Kato H (1982) Regression of aneurysms in Kawasaki disease: a pathological study? J Pediatr 100:225–231PubMedCrossRefGoogle Scholar
  29. 29.
    Suda K, Iemura M, Nishiono H, Teramachi Y, Koteda Y, Kishimoto S, Kudo Y, Itoh S, Ishii H, Ueno T, Tashiro T, Nobuyoshi M, Kato H, Matsuishi T (2011) Long-term prognosis of patients with Kawasaki disease complicated by giant coronary aneurysms: a single-institution experience. Circulation 123:1836–4218PubMedCrossRefGoogle Scholar
  30. 30.
    Sugahara Y, Ishii M, Muta H, Iemura M, Matsuishi T, Kato H (2008) Warfarin therapy for giant aneurysm prevents myocardial infarction in Kawasaki disease. Pediatr Cardiol 29:398–401PubMedCrossRefGoogle Scholar
  31. 31.
    Sugimura T, Kato H, Inoue O, Takagi J, Fukuda T, Sato N (1992) Vasodilatory response of the coronary arteries after Kawasaki disease: evaluation by intracoronary injection of isosorbide dinitrate. J Pediatr 121:684–688PubMedCrossRefGoogle Scholar
  32. 32.
    Takahashi M, Mason W, Lewis AB (1987) Regression of coronary aneurysms in patients with Kawasaki syndrome. Circulation 75:387–394PubMedCrossRefGoogle Scholar
  33. 33.
    Tanaka N, Naoe S, Masuda H, Ueno T (1986) Pathological study of sequelae of Kawasaki disease (MCLS), with specific reference to the heart and coronary arterial lesions. Acta Pathol Jpn 36:1513–1527PubMedGoogle Scholar
  34. 34.
    Tatara K, Kusakawa S, Itoh K, Honma S, Hashimoto K, Kazuma N, Lee K, Asai T, Murata M (1991) Collateral circulation in Kawasaki disease with coronary occlusion or severe stenosis. Am Heart J 121:797–802PubMedCrossRefGoogle Scholar
  35. 35.
    Tsuda E, Kamiya T, Ono Y, Kimura K, Kurosaki K, Echigo S (2005) Incidence of stenotic lesions predicted by acute phase changes in coronary arterial diameter during Kawasaki disease. Pediatr Cardiol 26:73–79PubMedCrossRefGoogle Scholar
  36. 36.
    Uehara R, Nakamura Y, Yanagawa H (2005) Epidemiology of Kawasaki disease in Japan. Jpn Med Assoc J 48:183–193Google Scholar
  37. 37.
    Velasco-Sanchez D, Lambert R, Turpin S, Laforge S, Fournier A, Lapierre C, Dahdah N (2012) Right ventricle myocardial perfusion scintigraphy: feasibility and expected values in children. Pediatr Cardiol 33:295–301PubMedCrossRefGoogle Scholar
  38. 38.
    Yamakawa R, Ishii M, Sugimura T, Akagi T, Eto G, Iemura M, Tsutsumi T, Kato H (1998) Coronary endothelial dysfunction after Kawasaki disease: evaluation by intracoronary injection of acetylcholine. J Am Coll Cardiol 31:1074–1080PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  • Ariane McNeal-Davidson
    • 1
  • Anne Fournier
    • 1
  • Rosie Scuccimarri
    • 2
  • Adrian Dancea
    • 3
  • Christine Houde
    • 4
  • Marc Bellavance
    • 5
  • Nagib Dahdah
    • 1
    Email author
  1. 1.Division of Pediatric CardiologyCHU Sainte-Justine, Université de MontrealMontrealCanada
  2. 2.Division of Pediatric RheumatologyMontreal Children’s Hospital, McGill UniversityMontrealCanada
  3. 3.Division of Pediatric CardiologyMontreal Children’s Hospital, McGill UniversityMontrealCanada
  4. 4.Division of Pediatric CardiologyCentre Hospitalier Universitaire de QuébecQuebecCanada
  5. 5.Division of Pediatric CardiologyCentre Hospitalier Universitaire de SherbrookeSherbrookeCanada

Personalised recommendations